Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma

Cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) reduces survival. In this study we hypothesized that methylation of key genes mediates cisplatin resistance. We determined whether a demethylating drug, decitabine, could augment the anti-proliferative and apoptotic effects of cis...

Descripción completa

Detalles Bibliográficos
Autores principales: Viet, Chi T., Dang, Dongmin, Achdjian, Stacy, Ye, Yi, Katz, Samuel G., Schmidt, Brian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229295/
https://www.ncbi.nlm.nih.gov/pubmed/25391133
http://dx.doi.org/10.1371/journal.pone.0112880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229295/
https://www.ncbi.nlm.nih.gov/pubmed/25391133
http://dx.doi.org/10.1371/journal.pone.0112880

Ejemplares similares